Traders Friendly Traders Friendly
  • Home
  • Latest News
  • Privacy Policy
  • Whitelisting
  1. Home
  2. Latest News
  3. Suspicious Theranos Test Didn’t Stop Fund’s $96 Million Buy-In
 Suspicious Theranos Test Didn’t Stop Fund’s $96 Million Buy-In
Latest News

Suspicious Theranos Test Didn’t Stop Fund’s $96 Million Buy-In

by November 17, 2021 0 Comment

TipRanks

2 Big Dividend Stocks Yielding 9%; Analysts Say ‘Buy’

With just seven weeks left in 2021, Wall Street’s big names are firming up their year-end forecasts. Mike Wilson, chief U.S. equity strategist at Morgan Stanley, has set a 4,400 target for the S&P 500 by the end of 2022. That implies a fall of 6% from current levels. In his forecast, Wilson points out the factors that are likely to weigh on the markets, including “uncertainty around that expectation goes up materially given cost pressures, supply issues, along with tax and policy uncertainty tha

Previous post
Next post

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright 2023. All Right Reserved By www.tradersfriendly.com